Natiijooyinka Hawlgallada Ka Hortagga Dheef-shiidka ee Glucosamine / Chondroitin

Natiijooyinka Maxkamadeynta Mareykanka iyo Yurub ayaa soo bandhigay Glucosamine

Kuliyadda Cilmi-baarista Sanadlaha ah ee Maraykanka (2005), natiijooyinka laga helay laba tijaabo oo glucosamine ah ayaa la soo bandhigay. Natiijooyinka labadii tijaabo ayaa si aad ah loo filayay cilmi-baarayaasha, dhakhaatiirta, iyo bukaanka kuwaas oo raadinayey xaqiijinta in glucosamine uu yahay ikhtiyaarka daaweynta ee arthritis .

GAIT (Maxkamadeynta Dhibaatada Glucosamine / Chondroitin) Dhismaha I

GAIT (Maxkamadeynta Farogelinta Glucosamine / Chondroitin Arthritis), qiyaastii 1,600 oo bukaan ah oo qaba jadeeco xanuunka osteoarthritis ayaa laga soo qaatay 16 xarumood ee rheumatolojiyada ee Maraykanka ee daraasadda. Ka-qaybgalayaasha daraasadu waxay la kulmeen xanuun jilicsan oo waxay leeyihiin raajo raajo oo ah osteoarthritis. Inta lagu jiro baaritaanka GAIT, bukaanka:

Natiijooyinka Ka GAIT (Maxkamadaynta Farogelinta Glucosamine / Chondroitin Arthritis)

GUIDE (Glucosamine Unum In Saameyn Dhimasho)

Waxaa jirey 318 bukaan oo daraasadda GUIDE qaba jadeecada osteoarthritis (88% haweenka). Bukaan-jiifka ayaa loo kala saaray si loo qaato budada glukosamine sulfate-ka ah (1500 mg hal mar maalintii), acetaminophen (1000 mg saddex jeer maalintii), ama placebo muddo 6 bilood ah. Dhammaan kooxaha ayaa loo oggolaaday inay qaataan ibuprofen sida loogu baahan yahay.

Natiijooyinka Laga soo bilaabo GUIDE (Glucosamine Unum In Saameyn Dhimasho)

Wajiga labaad iyo Wajiga III GAIT Natiijooyinka

Natiijooyinka laga soo qaatay marxaladda labaad ee daraasadda GAIT waxaa lagu daabacay wargayska Arthritis & Rheumatism ee 2008. Wejigii 2aad ayaa qiimeeyey isku-dhafka glucosamine iyo chondroitin si looga hortago dhaawaca wadajirka ah ee jilibka. Isku daridda glucosamine iyo chondroitin waxay u muuqatay mid aan waxtar badan lahayn si looga hortago dhaawaca wadajirka ah ee la xiriira osteoarthritis marka loo eego placebo.

Ka-qaybqaatayaasha ka yimi qadarka ugu yar ee isku-dhafan ee labada sano ka mid ah waxay ka mid ahaayeen kooxaha qaatay glucosamine ama chondroitin oo keliya. Waxaa suurtagal ah, qaadashada labada taakuleeyba waxay wadaagaan saameynta nuucista, kaas oo sharxi kara waxtarka yar ee waxtarka marka la isticmaalayo isku-darka.

Wajiga III, oo tixgeliyey wadar ahaan afar sano oo xog ah, ayaa shaaca ka qaaday in dheeraadka ama iskuduubnaanta ayan wax faa'iido ah ka helin xanuunka nabarka ee ka soo jeeda jadeecada ama xargaha. Natiijooyinka waxaa la daabacay sannadkii 2010-ka wargeyska Annals of Rheumatic Disease .

Talooyinka loogu talagalay Glucosamine

Khadadka hoose

Sanadkii 2012, College College of Rheumatology ayaa soo bandhigtay talooyinka daaweynta ee loogu talagalay osteoarthritis. Xeerarka, chondroitin ama glukosamine laguma talineynin daaweynta bilowga ah ee osteoarthritis. Kondroitin iyo glucosamine supplements oo keliya ama isku dhafan ma noqon karaan daaweyn wax ku ool ah dhammaan bukaanada. Waxay u shaqeyn kartaa bukaanada qaarkood, iyo haddii ay kuu shaqeyneyso, sii wad daaweynta - waxaa loo tixgelinayaa amaan.

Ilaha:

Saameynta glucosamine iyo / ama chondroitin sulfate oo ku saabsan horumarka osteoarthritis-ka: Warbixin ka timid tijaabada daaweynta glucosamine / chondroitin arthritis. Sawitzke et al. Arthritis & Rheumatism. 2008 Oktoobar; 58 (10): 3183-91.
http://www.ncbi.nlm.nih.gov/pubmed/18821708

Maxkamadeynta Farogelinta Arthritis (GAIT) ee Glucosamine / Chondroitin. NIH. Bedelay Janaayo 2012.
https://nccih.nih.gov/research/results/gait

Waxtarka caafimaadka iyo nabadgelyada glukosamine, chondroitin sulphate, isku dhafka, celecoxib ama placebo loo qaato si loogu daaweeyo osteoarthritis ee jilibka: natiijooyinka 2-sanno laga bilaabo GAIT. Juun 2010. Annalska Cudurka Rootiga. 2010; 69: 1459-1464
http://ard.bmj.com/content/69/8/1459.abstract?sid=fc95aeb7-1d79-4a79-9dac-c65916ca2125

Talooyinka loogu talagalay Isticmaalka Qalabka Cilmi-baarista iyo Xaqiiqooyinka Faragelinta ee Osteoarthritis-ka ee Hand gacmeed, Hip, iyo Jilib. Jaamacadda Rheumatology 2012. (Arthritis Care & Research Volume 64, Tirada 4, Abriil 2012, pp 465-474.)